ImmunologybioRxivPreprint
The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenance.
B. A. Johnson, A. K. Aragaki, D. M. Williams…·L. M. S. Resar
This study shows that inhibiting the IDO1 pathway reduces tumor-infiltrating B cells in melanoma models, suggesting potential therapeutic strategies for solid tumors.